Treatment

- Croscarmellose Sodium clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Dementia with Lewy Bodies (DLB)
This study is looking at a new medicine called neflamapimod for people with a type of memory problem called Dementia with Lewy Bodies (DLB). It aims to see if this medicine can help improve memory and thinking over 16 weeks.
Netherlands